day 1 agenda

Mon , Jun 10, 2019

  • 08:00
  • Registrations

  • 08:45
  • Opening Ceremony & Welcome Speech

  • 09:00
  • Keynote Talk-1 : 3D Printed Corneal Equivalent

    Sachdeva Mandip S, Professor of Pharmaceutics, Florida A&M University, USA

  • 09:30
  • Keynote Talk-2 : Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

    Kaliappanadar Nellaiappan, Director of Product Development at Curirx inc, USA

     

  • 10:00
  • Keynote Talk 3 : Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: Enhancing solubility for better cellular delivery

    Reem K. Arafa, Professor of Biomedical Sciences, Zewail City of Science and Technology, Egypt

  • 10:30
  • Keynote Talk-4: Lung Delivery of Biopharmaceuticals using Nanocarrier Systems

    Imran Saleem, Reader in Nanomedicine, Liverpool John Moores University, UK

  • 11:00
  • Refreshments

  • 11:20
  • High gene delivery efficiency mediated by lipid- and polymer-based nanosystems

    Henrique Faneca, Center for Neuroscience and Cell Biology, University of Coimbra,Portugal

  • 11:40
  • Scientific Session : Targeting c-MYC and c-MYC regulating microRNAs in ovarian cancer with liposomal-interference RNA

    Pablo Vivas-Mejia, Assistant professor in the Cancer Center and the Department of Biochemistry of the University of Puerto Rico Medical Sciences, Puerto Rico

  • 12:00
  • Scientific Session : Cell-based chemoresistance models to evaluate combinational nanoformuations

    Badiree Konkimalla, Reader-F, National Institute of Science Education and Research (NISER), India

  • 12:20
  • Scientific Session: Inorganic Nanomaterials as Carriers in Targeted Delivery of Anticancer Drugs

    R.M.G. Rajapakse, University of Peradeniya, Sri Lanka 

  • 12:40
  • Nanoparticle Engineering towards Highly Efficient Drug Delivery Systems and SERS-based Bio-Sensing

    Beatrice Fortuni, KU Leuven, Belgium

  • 13:00
  • Lunch at Restaurant

  • 13:45
  • Group photo

  • 13:50
  • Scientific Session : The Importance of Modernization of Acetaminophen (Paracetamol) containing Documentary Standards to Global Public Health

    Clydewyn Anthony, United States Pharmacopeial Convention, USA

  • 14:10
  • Scientific Session : Marine Compound Xyloketal B as a Novel Drug Candidate for Cardiovascular and neuronal protection

    Guan-Lei Wang, Professor of Pharmacology, Sun Yat-sen University, China

  • 14:30
  • Scientific session : Amino acid based surfactants: a class of amphiphiles with potential applications in the pharmaceutical field

    Diego Romano Perinelli, School of Pharmacy, University of Camerino, Italy

  • 14:50
  • Scientific Session : Development and Pharmacokinetic Evaluations of a Co-Solvent and a PLGA-based Nanospheres of Itraconazole for Intravenous Administrations

    Dong Liang, Texas Southern University, USA

  • 15:10
  • Scientific session : Subcutaneous formulation of furosemide: endless opportunities for an old drug.

    Tamas Alexy, Assistant Professor, Medicine/Cardiology, University of Minnesota, USA

  • 15:30
  • Scientific Session : Treatment of animal model for hot flushes by nasal administration of a non-hormonal drug delivery system

    Hiba Natsheh, Post-doctoral fellow at The Hebrew University, Israel

  • 15:50
  • Coffee Break

  • 16:10
  • Special Session: Phytochemical compounds of Selected Lebanese Plants with Potential Biological activities

    Maha Aboul-Ela, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Lebanon​

  • 16:30
  • Special Session: Contribution of Developed Prototype Research Software Relevant to Infants’ Prakriti (Physical constitution) Assessment for Vikriti (Pathological condition) Management and Possible Future Disorders

    Srivastava Niraj , Government Ayurvedic PG College, India

  • 16:50
  • Special Session : Role of Leech Therapy in Different Diseases W.S.R. Deep vein Thrombosis (DVT)

    Varsha Saxena, Uttarakhand  Ayurveda University (UAU), India

  • 17:10
  • Panel Discussion

  • Note:
  • This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots

day 2 agenda

Tue , Jun 11, 2019

  • 08:30
  • Registrations

  • 09:00
  • Keynote Talk-1: Bridging Discovery program to Development-The Making of a Phase I Trial Study

    Elizabeth Kwong,  Director & CEO of Kwong Eureka Solutions, Canada

  • 10:10
  • Keynote Talk-3 : Material properties impacting micronization behavior of a crystalline drug

    Ajit Narang, Sr. Scientist, Genentech, Inc., USA

  • 10:10
  • Keynote Talk 4: Development of a novel anti-Ran-GTPase peptide nanoparticles as a novel approach for anti-metastatic therapies

    Ahmed Faheem, University of Sunderland, UK

  • 10:40
  • Keynote Talk 4: Development of integrated enzymatic electrophoretic methodologies for the quality control of therapeutic biomolecules

    Catherine Perrin, Professor in analytical chemistry at the faculty of pharmacy of Montpellier (University of Montpellier), France

  • 11:10
  • Refreshments

  • 11:30
  • Scientific Session : Biorelevant Dissolution to Facilitate Formulation Development of a BSC Class 2 Basic Compound and Overcome Drug-Drug Interaction with Acid Reducing Agents

    Dawen Kou, Senior Scientist in Genentech at South San Francisco, CA, USA

  • 11:50
  • Scientific Sessions : Our smeared FE computational models for drug delivery in organs and tumors

    Milos Kojic, Houston Methodist, BioIRC Research Center, Serbian Academy of Sciences and Arts, Serbia

  • 12:10
  • Scientific Session : Divorce uses of gabapentenoids and it’s implications- a new public health issue

    Shubhakaran Khichar, Professor of Neurology at Government Medical College, India

  • 12:30
  • Scientific Session: Chiral HPLC Resolution of a Potentially Serious Global Health Crisis

    Clydewyn Anthony, United States Pharmacopeial Convention, USA

     

  • 12:50
  • Scientific Session: Patient Registries and the EU Regulatory Framework: Some Reflections

    Charlotte Ryckman, Covington & Burling LLP

  • 13:20
  • Lunch at Restaurant

  • 14:10
  • Scientific Session : Precision Medicine Collaborations at the Industry-Academic Interface

    Patrick J Silva, University of Arizona Health Sciences, USA

  • 14:30
  • Scientific session : A Pharmacokinetic Study of Medazolam and Ketamine in Patients on Extracorporeal Membrane Oxygenation Therapy

    Gagan Kaushal, Associate Professor in Pharmaceutics, Thomas Jefferson University, USA

  • 14:50
  • Scientific Session: Analysis 3-Hydroxypropyl Mercapturic Acid (3-HPMA) in Urine of Breast Cancer Patient for Monitoring the Toxicity of Cyclophosphamide

    Yahdiana Harahap, Faculty of Pharmacy, Universitas Indonesia, Indonesia

  • 15:10
  • Scientific Session: Bactericidal autophagy inhibitors in cancer treatment

    Benedetto Grimaldi , Italian Institute of Technology (IIT), Italy

  • 15:30
  • Scientific Session : In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin

    Ruba S. Darweesh, Assistant Professor of Pharmaceutical Sciences, Jordan University of Science and Technology, Jordan

  • 15:50
  • Scientific Session : 3D Bioprinting Substitute Encapsulated with Cells and Growth Factor

    Lei Nie, KU Leuven, Belgium

  • 16:10
  • Scientific Session : Spiro-fused cyclopropa[a]pyrrolizines and 3-azabicyclo[3.1.0]hexanes as potential antitumor agents

    Vitali M Boitsov, Saint-Petersburg Academic University, St Petersburg, Russian Federation, 

  • 16:30
  • Coffee Break

  • 16:50
  • Panel Discussion

  • Note:
  • This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots

day 3 agenda

Wed , Jun 12, 2019

  • 10:00
  • Networkig

  • 12:30
  • Lunch at Restaurant

Conference Agenda Download